Japan Said To Seek Stiff Regulation Of iPS Technolgy, Including Treatment
This article was originally published in PharmAsia News
Executive Summary
Japan proposes regulating the use of induced pluripotent stem cells, covering the method in general as well as the therapy associated with it, according to sources.